Found 14 matching trials
A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
PHASE2This is a safety and efficacy study evaluating a experimental treatment for...
Location
Site Reference ID/Investigator# 75139
A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease
PHASE1This study will investigate safety, tolerability and pharmacokinetics of AB...
Location
Site Reference ID/Investigator# 62908
Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease
PHASE2This is a long term extension study to evaluate safety and tolerability of ...
Location
Site Reference ID/Investigator# 84185
A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
PHASE2This is an efficacy study evaluating a experimental treatment for cognitive...
Location
Site Reference ID/Investigator# 74436
A Safety and Tolerability Study of ABT-126 in Elderly
PHASE1The objectives of this study are to assess the safety, tolerability and pha...
Location
Site Reference ID/Investigator# 17283
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
PHASE2This is a study of ABT-126 in the treatment of cognitive impairment associa...
Location
Site Reference ID/Investigator# 95398
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
PHASE2This is an efficacy and safety study evaluating a new treatment for subject...
Location
Site Reference ID/Investigator# 56503
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
PHASE2This is an efficacy and safety study evaluating a new treatment for subject...
Location
Site Reference ID/Investigator# 66528
This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease
PHASE2This is a long term extension study to evaluate safety and tolerability of ...
Location
Site Reference ID/Investigator# 73493
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
PHASE2This is an efficacy and safety study evaluating an experimental treatment f...
Location
Site Reference ID/Investigator# 26267